VSE CORP

VSECU

Held by 1 specialist biotech fund

Fund Holdings

AI Signal

**Signal Note: Driehaus Growth Entry into VSE Corp** VSE is a defense contractor and distributor, not a biotech company—this appears to be a data error or ticker mismatch.

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 520,237Value: $89.9M

**Signal Note: Driehaus Growth Entry into VSE Corp** VSE is a defense contractor and distributor, not a biotech company—this appears to be a data error or ticker mismatch. Driehaus's $89.9M position would represent a significant growth allocation bet, but without clarification on the actual underlying asset or thesis, the clinical/regulatory catalyst cannot be assessed. *Recommendation: Verify ticker and company classification before drawing investment conclusions.*

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: